Zhitong Finance App News, Kangchen Pharmaceutical (01681) issued an announcement. The company adopted the 2013 share purchase plan on December 2, 2013. According to the terms of the 2013 Share Option Plan, unless otherwise terminated or amended, the 2013 Share Option Plan will be valid for 10 years from the date of its adoption and will expire on December 1, 2023. After the expiration of the 2013 share option plan, no share options will be offered or granted. As of the date of this announcement, there were still 504.63,900 share options granted but not yet exercised in the 2013 share option plan.
In view of the expiration of the 2013 share option plan, the Board recommended adopting the 2024 share option plan in accordance with Chapter 17 of the revised listing rules, effective from 1 January 2023 to motivate or reward eligible participants for their contributions to the Group.